- Home
- LKFN vs TSHA Comparison
LKFN vs TSHA Comparison
Compare LKFN & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LKFN | TSHA |
|---|---|---|
| Founded | 1872 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2009 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LKFN | TSHA |
|---|---|---|
| Price | $56.50 | $4.62 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $67.00 | $10.56 |
| AVG Volume (30 Days) | 123.4K | ★ 2.1M |
| Earning Date | 04-27-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.67% | N/A |
| EPS Growth | 10.47 | ★ 62.50 |
| EPS | ★ 4.01 | N/A |
| Revenue | $985,000.00 | ★ $8,333,000.00 |
| Revenue This Year | $15.08 | N/A |
| Revenue Next Year | $5.18 | N/A |
| P/E Ratio | $14.15 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $50.00 | $1.13 |
| 52 Week High | $69.38 | $6.02 |
Technical Indicators
Market Signals| Indicator | LKFN | TSHA |
|---|---|---|
| Relative Strength Index (RSI) | 38.19 | 47.58 |
| Support Level | N/A | $4.41 |
| Resistance Level | $61.59 | $5.16 |
| Average True Range (ATR) | 1.67 | 0.20 |
| MACD | -0.30 | 0.00 |
| Stochastic Oscillator | 31.31 | 35.71 |
Price Performance
Historical ComparisonAbout LKFN Lakeland Financial Corporation
Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.